B
Becky A. Briesacher
Researcher at Northeastern University
Publications - 118
Citations - 5325
Becky A. Briesacher is an academic researcher from Northeastern University. The author has contributed to research in topics: Prescription drug & Medical prescription. The author has an hindex of 39, co-authored 111 publications receiving 4829 citations. Previous affiliations of Becky A. Briesacher include Leonard Davis Institute of Health Economics & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
Comparison of drug adherence rates among patients with seven different medical conditions.
TL;DR: To compare drug adherence rates among patients with gout, hypercholesterolemia, hypertension, hypothyroidism, osteoporosis, seizure disorders, and type 2 diabetes mellitus by using a standardized approach.
Journal ArticleDOI
Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature
TL;DR: Older patients with chronic diseases and mood disorders are at-risk for CRN even if enrolled in Medicare’s new drug benefit, and efforts to reduce cost-related medication nonadherence would benefit from greater study of factors besides the presence of prescription drug coverage.
Journal ArticleDOI
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
Jeanne M. Madden,Amy J. Graves,Fang Zhang,Alyce S. Adams,Becky A. Briesacher,Dennis Ross-Degnan,Jerry H. Gurwitz,Marsha Pierre-Jacques,Dana Gelb Safran,Gerald R. Adler,Stephen B. Soumerai +10 more
TL;DR: There was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation, and no net decrease inCRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.
Journal ArticleDOI
The quality of antipsychotic drug prescribing in nursing homes.
Becky A. Briesacher,M. Rhona Limcangco,Linda Simoni-Wastila,Jalpa A. Doshi,Jalpa A. Doshi,Suzi R. Levens,Dennis G. Shea,Bruce Stuart +7 more
TL;DR: This study detected the highest level of antipsychotic use in NHs in over a decade, with most atypicals prescribed outside the prescribing guidelines and for doses and indications without strong clinical evidence.
Journal ArticleDOI
The incident user design in comparative effectiveness research.
Eric S. Johnson,Barbara A. Bartman,Becky A. Briesacher,Neil S. Fleming,Tobias Gerhard,Cynthia J. Kornegay,Parivash Nourjah,Brian C. Sauer,Glen T. Schumock,Art Sedrakyan,Til Stürmer,Suzanne L West,Sebastian Schneeweiss +12 more
TL;DR: This article takes the incident user design as a reasonable default strategy because it reduces biases that can impact non‐randomized studies, especially when investigators use healthcare databases.